Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
- PMID: 32247193
- PMCID: PMC7105910
- DOI: 10.1016/j.jns.2020.116803
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
Comment in
-
Myasthenic crisis in COVID-19.J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6. J Neurol Sci. 2020. PMID: 32413767 Free PMC article.
-
Management of patients with generalised myasthenia gravis and COVID-19: four case reports.J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10. J Neurol Neurosurg Psychiatry. 2020. PMID: 32651248 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
